While AstraZeneca lags far behind its Novo Nordisk and Lilly competitors in the weight loss space, AstraZeneca contends that Eccogenes oral molecule could offer viable alternatives to the current injectable therapies from those two companies
One day you thought, Hey, lets do a study where we compare our new fancy drug against our direct competitor currently on the market. If that study shows your competitor has the better drug, well, someone will likely be losing their job
Retatrutide is currently in Phase 3 clinical trials, with seven additional trials expected to report results in 2026
Glucagon Receptor: While glucagon traditionally raises blood glucose, its activation in this context is complex
Patients who have suffered from severe gastrointestinal issues after using Ozempic are seeking compensation for their medical expenses, pain, and suffering
Precision Peptide Genetic Testing for Fertility and Metabolism PlexusDx offers the Precision Peptide Genetic Test ($298) to identify how your unique genetic variants affect weight regulation, appetite, and metabolic hormones